Vivos Therapeutics (VVOS) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-3.05
-2.17
-1.28
-0.4

Details

Expected EPS
-0.655
Actual EPS
-0.4
Surprise EPS
0.26
Surprise Percent
+38.93%

Description

⁨Vivos Therapeutics⁩ (⁦VVOS⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts